All Terrain Financial Advisors’s Pfizer PFE Stock Holding History

All Terrain Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,476	Closed	-$46K	–	152
2020 Q1	$46K	Sell	1,476 -421	-22%	-$14.3K	0.02%	164
2019 Q4	$71K	Hold	1,897	–	–	0.02%	187
2019 Q3	$65K	Hold	1,897	–	–	0.02%	189
2019 Q2	$78K	Hold	1,897	–	–	0.03%	175
2019 Q1	$76K	Hold	1,897	–	–	0.03%	197
2018 Q4	$79K	Hold	1,897	–	–	0.03%	172
2018 Q3	$79K	Buy	+1,897	New	+$73K	0.03%	198

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

All Terrain Financial Advisors's PFE Position: Q4 2023 in Review

All Terrain Financial Advisors sold out of Pfizer (PFE) in Q4 2023, closing a stake of 88,130 shares — an estimated $2.92M sold.

All Terrain Financial Advisors first reported a position in PFE in Q4 2017 and held it in 24 quarters. The position peaked at $4.48M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

All Terrain Financial Advisors reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
All Terrain Financial Advisors sold 88,130 Pfizer shares in Q4 2023, an estimated $2.92M.
All Terrain Financial Advisors first reported a position in Pfizer in Q4 2017 and held it in 24 quarters.
All Terrain Financial Advisors's Pfizer position peaked at $4.48M in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on All Terrain Financial Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.